PLASMIN‐α2‐ANTIPLASMIN COMPLEX AS AN INDICATOR OF IN VIVO FIBRINOLYSIS
- 1 March 1982
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 50 (3) , 537-541
- https://doi.org/10.1111/j.1365-2141.1982.tb01950.x
Abstract
.alpha.2-Antiplasmin is the principal plasma inhibitor of plasmin, with which it rapidly and irreversibly forms a complex. The simple technique of crossed immunoelectrophoresis against antiserum to .alpha.2-antiplasmin was applied to detect plasmin-.alpha.2-antiplasmin complex in plasma. The presence of this complex was demonstrated in patients in whom overactive fibrinolysis was the only or major contributor to severe hemorrhagic disorders arising spontaneously.This publication has 10 references indexed in Scilit:
- Comparative Studies on Human Activators of PlasminogenBritish Journal of Haematology, 1981
- On the Regulation and Control of FibrinolysisThrombosis and Haemostasis, 1980
- IMMUNOCHEMICAL CHARACTERIZATION OF THE PLASMIN-ANTIPLASMIN SYSTEM - BASIS FOR THE SPECIFIC DETECTION OF THE PLASMIN-ANTIPLASMIN COMPLEX BY LATEX AGGLUTINATION ASSAYS1979
- Biochemical Changes Noted during Intermittent Administration of StreptokinaseThrombosis and Haemostasis, 1978
- Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrateScandinavian Journal of Clinical and Laboratory Investigation, 1977
- The primary inhibitor of plasmin in human plasmaBiochemical Journal, 1976
- Studies on the Nature of Antihemophilic Factor (Factor VIII)Journal of Clinical Investigation, 1973
- The fibrinolytic enzyme system in hypertensionJournal of Clinical Pathology, 1973
- Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodiesAnalytical Biochemistry, 1966